Stemline Therapeutics
ELZONRIS
Manufacturer:
Stemline Therapeutics
Name:
ELZONRIS
HCPCS Code Descriptor:
Injection, tagraxofusp-erzs, 10 micrograms
Category:
J Code
HCPCS:
J9269
NDC(s):
72187-0401-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ELZONRIS is an Oncology drug manufactured by Stemline Therapeutics and administered via the Intravenous route of administration. The J Code: J9269 is aligned to the drug ELZONRIS.
Access Pricing and More By Registering
HCPCS Added Date:
10/1/19
HCPCS Effective Date:
10/1/19
HCPCS Short Description:
Inj. tagraxofusp-erzs 10 mcg
Billing and Coding Guide:
https://www.elzonris.com/hcp/content/documents/Coding_and_Billing_Guide.pdf
Patient Assistance:
https://elzonris.com/hcp/stemline-arc-summary/